Krystal Biotech, Inc. Common Stock
KRYS Real Time Price USDRecent trades of KRYS by members of U.S. Congress
| Politician | Type | Traded |
|---|---|---|
| Chris Jacobs House / R | Purchase $1,001 - $15,000 | Dec. 12, 2022 |
|
Name
|
Type
|
Shares
|
Price
|
Shares Held
|
Date
|
Reported
|
|---|
|
Investor
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
|
Investor
|
Type
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
Recently reported changes by institutional investors
Quarterly net insider trading by KRYS's directors and management
Government lobbying spending instances
Estimated quarterly lobbying spending
New patents grants
-
Patent Title: Recombinant nucleic acids encoding cosmetic protein(s) for aesthetic Oct. 29, 2024
-
Patent Title: Viral vectors for cancer therapy Mar. 05, 2024
-
Patent Title: Methods of delivering transgenes to the eye Jan. 09, 2024
-
Patent Title: Viral vectors for cancer therapy Oct. 10, 2023
-
Patent Title: Compositions and methods for the treatment of autosomal recessive congenital ichthyosis Aug. 08, 2023
-
Patent Title: Compositions and methods for the treatment of netherton syndrome May. 09, 2023
-
Patent Title: Compositions and methods for the treatment of wounds, disorders, and diseases of the skin Nov. 30, 2021
-
Patent Title: Compositions and methods for delivering cftr polypeptides Nov. 10, 2020
-
Patent Title: Recombinant nucleic acids encoding cosmetic protein(s) for aesthetic applications Sep. 29, 2020
-
Patent Title: Compositions and methods for the treatment of autosomal recessive congenital ichthyosis Jan. 07, 2020
-
Patent Title: Compositions and methods for the treatment of wounds, disorders, and diseases of the skin Oct. 15, 2019
-
Patent Title: Compositions and methods for the treatment of wounds, disorders, and diseases of the skin Dec. 18, 2018
-
Patent Title: Compositions and methods for the treatment of wounds, disorders, and diseases of the skin Jan. 30, 2018
Federal grants, loans, and purchases
Estimated quarterly amount awarded from public contracts
Number of mentions of KRYS in WallStreetBets Daily Discussion
Recent insights relating to KRYS
Recent picks made for KRYS stock on CNBC
ETFs with the largest estimated holdings in KRYS
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.Sign Up to view KRYS Smart Score
See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.
Example:
The Bulls Say summary highlights positive aspects of the stock.
The Bears Say summary points out potential risks and negative aspects of the stock.